Compare Tenet Healthcare Corporation (THC) vs Block Inc (XYZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tenet Healthcare Corporation vs Block Inc — how do they compare? Tenet Healthcare Corporation trades at $260.91 (market cap $20.98B), while Block Inc trades at $77.43 (market cap $45.20B). The key difference: Block Inc is far larger — about 2.2× Tenet Healthcare Corporation's market cap, and Tenet Healthcare Corporation is more actively traded (428,008 versus 8,386,094). Which is the better fit depends on your goals — on Pluang, investors hold Tenet Healthcare Corporation for 15 Days and Block Inc for 78 Days on average.
| THC | XYZ | |
|---|---|---|
Market Cap | $20.98B | $45.20B |
Volume | 428,008 | 8,386,094 |
Sector | Health | Technology |
52-Week High | $280.77 | $84.85 |
52-Week Low | $161.37 | $49.04 |
Typical Hold Time | 15 Days | 78 Days |
Enterprise Value | $32.06B | $40.10B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Tenet Healthcare (THC) trades at $259.83, up 0.53% with a bullish technical signal. The stock shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and robust profitability (ROE 53.31%, net margin 9.9%). Recent news highlights strong cash flow supporting capital returns and upcoming Q3 2026 results on October 29. Valuation appears reasonable with P/E of 10.07 and EV/EBITDA of 5.75.
THC presents a compelling investment case with strong analyst support (81% buy ratings) and 7% upside to consensus target of $283.36. Key catalysts include sustained earnings momentum and efficient capital allocation. Risks include surgical volume pressures and cash flow sustainability concerns amid aggressive buybacks. The stock's current technical setup near pivot point $259 suggests balanced risk-reward.
XYZ (Block Inc.) trades at $76.07, down 0.64% today, with a bearish technical signal despite strong analyst support. The stock shows mixed fundamentals with a high P/E ratio of 134.34 but solid revenue growth from $24.19B in 2025 to projected $25.0B in 2026. Recent earnings beats in Q1 and Q2 2026 contrast with Q4 2025's miss, while net income margin compression from 12.01% to 1.42% raises profitability concerns. Positive developments include Square platform expansions and potential federal trust bank approval.
XYZ presents a conflicted investment case with Wall Street optimism (76.9% buy ratings, $97.47 target) offset by valuation concerns and margin pressure. Near-term catalysts include Q3 2026 earnings on November 3, 2026, and banking charter progress. Key risks include intense fintech competition, execution challenges in Bitcoin operations, and insider selling activity. The stock trades near support at $75 with resistance at $77, requiring earnings acceleration to justify premium valuation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →About Block Inc
Founded in 2009, Block provides payment acquiring services to merchants, along with related services. The company also launched Cash App, a person-to-person payment network. Block has operations in Canada, Japan, Australia, and the United Kingdom
Read more on XYZ →
